Microbial cell surface and macromolecules

Microbial cell surface and macromolecules is a broad pharmacological classification used to describe a diverse set of structural and functional components found in bacteria and fungi that serve as sites for drug action (DrugBank, DB00651). This category includes the bacterial cell wall (peptidoglycan), the outer membrane of Gram-negative bacteria (lipopolysaccharides), and various fungal cell wall components like chitin and beta-glucans (StatPearls, NBK442032). These structures are vital for maintaining the osmotic stability and structural integrity of the microbe, as well as facilitating adherence to host tissues and evasion of the immune system (PubMed, PMID: 31633481). Antimicrobial agents such as beta-lactams, glycopeptides, and polymyxins target these macromolecules to induce cell lysis or growth arrest (NIH). Because many of these targets are absent in mammalian cells, they allow for high selective toxicity, making them cornerstones of infectious disease treatment. However, this term is considered a non-specific grouping rather than a single molecular target, encompassing a wide variety of distinct biochemical pathways and structures.

Other names

Bacterial cell wallFungal cell wallMicrobial surface componentsMicrobial cell envelopeBacterial macromolecules

Drugs targeting the microbial cell surface and macromolecules typically act by inhibiting the synthesis of essential structural components like peptidoglycan, disrupting the physical integrity of the cell membrane, or binding to specific surface molecules to neutralize microbial activity (StatPearls, NBK442032; PubMed, PMID: 29439581).